These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 1486544)
1. Functional capacity of patients with atrial fibrillation and controlled heart rate before and after cardioversion. Kubac G; Malowany L Can J Cardiol; 1992 Nov; 8(9):941-6. PubMed ID: 1486544 [TBL] [Abstract][Full Text] [Related]
2. Improvement in exercise performance after successful cardioversion in patients with persistent atrial fibrillation and symptoms of heart failure. Wozakowska-Kapłon B; Opolski G Kardiol Pol; 2003 Sep; 59(9):213-23. PubMed ID: 14618198 [TBL] [Abstract][Full Text] [Related]
3. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study. Wozakowska-Kapłon B; Opolski G Int J Cardiol; 2004 Aug; 96(2):171-6. PubMed ID: 15262030 [TBL] [Abstract][Full Text] [Related]
4. Impact of sinus rhythm restoration and maintenance on left ventricular function and exercise tolerance in patients with persistent atrial fibrillation. Kosior DA; Stawicki S; Wozakowska-Kapłon B; Szulc M; Opolski G; Rabczenko D Kardiol Pol; 2005 Jul; 63(7):36-47; discussion 48-9. PubMed ID: 16136427 [TBL] [Abstract][Full Text] [Related]
5. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods. Naegeli B; Straumann E; Bertel O Int J Cardiol; 2005 Mar; 99(2):283-7. PubMed ID: 15749188 [TBL] [Abstract][Full Text] [Related]
6. Atrial fibrillation: rate control often better than rhythm control. Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984 [TBL] [Abstract][Full Text] [Related]
7. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation. Frick M; Darpö B; Ostergren J; Rosenqvist M Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301 [TBL] [Abstract][Full Text] [Related]
8. [Initial clinical experiences with low energy internal cardioversion of chronic atrial fibrillation after unsuccessful external cardioversion]. Heisel A; Jung J; Rippl E; Fries R; Stopp M; Fröhlig G; Schieffer H; Ozbek C Z Kardiol; 1996 Dec; 85(12):943-8. PubMed ID: 9082672 [TBL] [Abstract][Full Text] [Related]
9. [Anticoagulation and electrical cardioversion of chronic atrial fibrillation: proposal for an abbreviated protocol]. Antonielli E; Pizzuti A; Gandolfo N; Sclavo M; Tanga M; Riva G; Leonardi G; Bassignana A; Di Leo M G Ital Cardiol; 1997 Aug; 27(8):803-10. PubMed ID: 9312508 [TBL] [Abstract][Full Text] [Related]
10. [The immediate and long-term efficacy of electrical cardioversion in atrial fibrillation]. Frabetti L; Carioli E; Antonioli P; Ferrari G; Magnani B Cardiologia; 1993 Sep; 38(9):561-7. PubMed ID: 8287385 [TBL] [Abstract][Full Text] [Related]
11. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation. Capucci A; Villani GQ; Aschieri D; Rosi A; Piepoli MF Eur Heart J; 2000 Jan; 21(1):66-73. PubMed ID: 10610746 [TBL] [Abstract][Full Text] [Related]
12. Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study. Lee JK; Klein GJ; Krahn AD; Yee R; Zarnke K; Simpson C; Skanes A; Spindler B Am Heart J; 2000 Dec; 140(6):871-7. PubMed ID: 11099990 [TBL] [Abstract][Full Text] [Related]
14. Brain natriuretic peptide predicts successful cardioversion in patients with atrial fibrillation and maintenance of sinus rhythm. Beck-da-Silva L; de Bold A; Fraser M; Williams K; Haddad H Can J Cardiol; 2004 Oct; 20(12):1245-8. PubMed ID: 15494777 [TBL] [Abstract][Full Text] [Related]
15. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study). Shelton RJ; Clark AL; Goode K; Rigby AS; Houghton T; Kaye GC; Cleland JG Heart; 2009 Jun; 95(11):924-30. PubMed ID: 19282313 [TBL] [Abstract][Full Text] [Related]
16. Signal-averaged P wave reflects change in atrial electrophysiological substrate afforded by verapamil following cardioversion from atrial fibrillation. Redfearn DP; Skanes AC; Lane J; Stafford PJ Pacing Clin Electrophysiol; 2006 Oct; 29(10):1089-95. PubMed ID: 17038141 [TBL] [Abstract][Full Text] [Related]
18. Increase in QT/QTc dispersion after low energy cardioversion of chronic persistent atrial fibrillation. Boriani G; Valzania C; Biffi M; Corazza I; Camanini C; Martignani C; Bacchi L; Zannoli R; Branzi A Int J Cardiol; 2004 Jun; 95(2-3):245-50. PubMed ID: 15193827 [TBL] [Abstract][Full Text] [Related]
19. [Cardioversion in atrial fibrillation. Results and complications in 1,152 prospective patients. Study Group of the Working Society of Leading Cardiologic Hospital Physicians]. Tebbe U; Carlsson J; Seidl K; Jansen W; Schuster HP; Elsner M; Neuhaus KL; Praetorius F Med Klin (Munich); 1995 Dec; 90(12):681-7. PubMed ID: 8583983 [TBL] [Abstract][Full Text] [Related]
20. Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion. Roijer A; Eskilsson J; Olsson B Eur Heart J; 2000 May; 21(10):837-47. PubMed ID: 10781356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]